B. Braun News 2016

Latest News

• Thursday, January 13, 2022

  B. Braun expands footprint in Vietnam with ground-breaking of new factory

  B. Braun celebrated the official ground-breaking of a state-of-the-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam on January 10, 2022.

  Read More
• Wednesday, December 8, 2021

  Dr Jens von Lackum appointed to the Management Board of B. Braun SE

  Melsungen. At its meeting on December 7th 2021, the Supervisory Board of B. Braun SE appointed Dr Jens von Lackum as deputy member of the Management Board of B. Braun SE.

  Read More
• Thursday, November 4, 2021

  Shaping the future of vascular stenting – REVA Medical and B. Braun form new partnership

  B. Braun and REVA Medical hereby announce the strategic partnership for the distribution of Fantom® Encore - a bioresorbable scaffold for coronary interventions, manufactured with REVA's patented material Tyrocore. B. Braun will start active distribution of the products in Germany and Switzerland in November 2021, with additional countries to follow soon.

  Read More
• Thursday, April 22, 2021

  Aesculap wins iF DESIGN AWARD with AESCULAP Aicon®

  Aesculap received together with its partner, the design agency Design3, an iF DESIGN AWARD 2021.

  Read More
• Thursday, March 25, 2021

  B. Braun business performance robust in 2020: firm foundation laid for continued growth in the next decade

  The B. Braun Group recorded € 7,426.3 million in sales in Fiscal Year 2020 (previous year: € 7,471.3 million).

  Read More
• Tuesday, March 23, 2021

  Changes in B. Braun SE Supervisory Board

  The Supervisory Board of the international medical technology and pharmaceutical company B. Braun has been reconstituted.

  Read More
• Monday, March 22, 2021

  Product Success: One million SeQuent® Please sold

  In December 2020, B. Braun Vascular Systems produced and sold its one millionth drug coated balloon catheter.

  Read More
• Friday, March 19, 2021

  Vaccination Supplies: Warning against Fraud Attempts with Supposed B. Braun Products

  Once again, individuals are attempting to abuse the coronavirus situation and distribute products necessary for coronavirus vaccination, such as syringes or needles, using counterfeit B. Braun business documents.

  Read More
• Tuesday, March 2, 2021

  B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®

  Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.

  Read More
• Thursday, August 27, 2020

  B. Braun Receives FDA Clearance for SpaceStation MRI

  Allows Space® Infusion Pumps to Continuously Deliver Medications Within the MRI Suite

  Read More